​

Lifecore Biomedical (LFCR) Stock Forecast, Price Target & Predictions

OverviewRevenueFinancialsChartTranscripts

LFCR Stock Forecast

Lifecore Biomedical (LFCR) stock forecast, based on 2 Wall Street analysts, predicts a 12-month average price target of $6.50, with a high of $8.00 and a low of $5.00. This represents a 7.44% increase from the last price of $6.05.

$4 $5 $6 $7 $8 $9 High: $8 Avg: $6.5 Low: $5 Last Closed Price: $6.05

LFCR Stock Rating

Lifecore Biomedical stock's rating consensus is Buy, based on 2 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 1 Buy (50.00%), 1 Hold (50.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 2 0 1 1 Strong Sell Sell Hold Buy Strong Buy

LFCR Forecast vs Benchmarks

TypeNameUpside
StockLifecore Biomedical7.44%
SectorHealthcare Stocks 25.20%
IndustrySpecialty & Generic Drug Manufacturers Stocks24.78%

Price Target Trends

1M3M12M
# Anlaysts--2
Avg Price Target--$6.50
Last Closing Price$6.05$6.05$6.05
Upside/Downside--7.44%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 25-12--3
Dec, 24-12--3
Nov, 24-12--3
Oct, 24-12--3
Sep, 24-12--3
Latest Price Target by Analysts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 04, 2024Jacob JohnsonStephens$5.00$5.38-7.06%-17.36%
Sep 05, 2024Matthew HewittCraig-Hallum$8.00$4.2289.57%32.23%
Latest Upgrade/Downgrade by Analysts
DateCompanyPrevious RatingNew RatingRating Change
Nov 22, 2024Craig-HallumBuyBuyhold
Oct 04, 2024StephensEqual-WeightEqual-Weighthold
Sep 05, 2024Craig-HallumBuyinitialise

Financial Forecast

EPS Forecast

$-4 $-3 $-2 $-1 $0 $1 May 20 May 21 May 22 May 23 May 24 May 25 May 26 May 27
May 20May 21May 22May 23May 24May 25May 26May 27
Reported$-1.31$-1.12$-1.56$-3.41$0.39---
Avg Forecast$-1.35$-1.03$-1.98$-2.38$0.41$-0.90$-0.63$-0.43
High Forecast$-1.36$-1.05$-2.00$-2.41$0.40$-0.92$-0.72$-0.45
Low Forecast$-1.32$-1.02$-1.94$-2.34$0.41$-0.88$-0.52$-0.40
Surprise %-2.96%8.74%-21.21%43.28%-4.88%---

Revenue Forecast

$100M $200M $300M $400M $500M $600M May 20 May 21 May 22 May 23 May 24 May 25 May 26 May 27
May 20May 21May 22May 23May 24May 25May 26May 27
Reported$590.37M$544.16M$185.79M$103.27M$128.26M---
Avg Forecast$590.21M$528.90M$183.76M$121.88M$125.39M$128.61M$138.69M$156.83M
High Forecast$582.13M$521.65M$181.24M$120.34M$123.81M$126.99M$136.94M$155.72M
Low Forecast$595.17M$533.33M$185.30M$122.96M$126.51M$129.76M$139.93M$157.94M
Surprise %0.03%2.89%1.10%-15.27%2.29%---

Net Income Forecast

$-150M $-110M $-70M $-30M $10M $50M May 20 May 21 May 22 May 23 May 24 May 25 May 26 May 27
May 20May 21May 22May 23May 24May 25May 26May 27
Reported$-38.19M$-32.66M$-46.08M$-102.19M$12.01M---
Avg Forecast$-49.31M$-37.90M$-72.46M$-87.04M$14.99M$-32.95M$-22.81M$-16.07M
High Forecast$-49.84M$-38.32M$-73.25M$-88.26M$14.78M$-33.77M$-26.48M$-16.50M
Low Forecast$-48.43M$-37.23M$-71.17M$-85.82M$15.20M$-32.13M$-19.14M$-14.66M
Surprise %-22.54%-13.82%-36.40%17.41%-19.88%---

LFCR Forecast FAQ

Is Lifecore Biomedical stock a buy?

Lifecore Biomedical stock has a consensus rating of Buy, based on 2 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 1 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Lifecore Biomedical is a favorable investment for most analysts.

What is Lifecore Biomedical's price target?

Lifecore Biomedical's price target, set by 2 Wall Street analysts, averages $6.5 over the next 12 months. The price target range spans from $5 at the low end to $8 at the high end, suggesting a potential 7.44% change from the previous close price of $6.05.

How does Lifecore Biomedical stock forecast compare to the average forecast of its sector, industry, and investment themes?

Lifecore Biomedical stock forecast shows a 7.44% upside, underperforming the average forecast for the healthcare stocks sector (25.20%) and underperforming the specialty & generic drug manufacturers stocks industry (24.78%).

What is the breakdown of analyst ratings for Lifecore Biomedical over the past three months?

  • January 2025: 0% Strong Buy, 33.33% Buy, 66.67% Hold, 0% Sell, 0% Strong Sell.
  • December 2024: 0% Strong Buy, 33.33% Buy, 66.67% Hold, 0% Sell, 0% Strong Sell.
  • November 2024: 0% Strong Buy, 33.33% Buy, 66.67% Hold, 0% Sell, 0% Strong Sell.

What is Lifecore Biomedical’s EPS forecast?

Lifecore Biomedical's average annual EPS forecast for its fiscal year ending in May is -0.9 for 2025, a -330.77% decrease from the reported $0.39 in 2024. The prediction for 2026 is $-0.63, and $-0.43 for 2027.

What is Lifecore Biomedical’s revenue forecast?

Lifecore Biomedical's average annual revenue forecast for its fiscal year ending in May is $128.61M for 2025, a 0.27% increase from the reported $128.26M in 2024. The forecast for 2026 is $138.69M, and $156.83M for 2027.

What is Lifecore Biomedical’s net income forecast?

For its fiscal year ending in May, Lifecore Biomedical's average annual net income forecast is $-32.95M for 2025, reflecting a -374.29% decrease from the reported $12.01M in 2024. The projection for 2026 is $-22.813M, and $-16.075M for 2027.